High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer

The search for the precursor of prostatic adenocarcinoma has focused in recent years on the spectrum of histopathologic changes referred to as high grade prostatic intraepithelial neoplasia (PIN). This review describes the diagnostic criteria and clinical significance of PIN.

[1]  T. Schultheiss,et al.  Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time. , 1993, International journal of radiation oncology, biology, physics.

[2]  D. Bostwick,et al.  Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.

[3]  B. Helpap.  Observations on the number, size and localization of nucleoli in hyperplastic and neoplastic prostatic disease , 1988, Histopathology.

[4]  F. Mostofi,et al.  Large acinar atypical hyperplasia and carcinoma of the prostate , 1988, Cancer.

[5]  D. Bostwick,et al.  Premalignant lesions of the prostate. , 1988, Seminars in diagnostic pathology.

[6]  T. Stamey,et al.  Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. , 1988, American journal of clinical pathology.

[7]  M. Brawer,et al.  Comparison of microscopic vascularity in benign and malignant prostate tissue. , 1993, Human pathology.

[8]  D. Siders,et al.  Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia. , 1989, Urology.

[9]  P. Lange,et al.  Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. , 1991, Urology.

[10]  M. Sporn,et al.  Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading. , 1994, Cancer research.

[11]  S. Maygarden,et al.  Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. , 1992, Archives of pathology & laboratory medicine.

[12]  A. Sandberg.  Chromosomal abnormalities and related events in prostate cancer. , 1992, Human pathology.

[13]  J. Epstein,et al.  Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels? , 1993, The Journal of urology.

[14]  T. Stamey,et al.  Keratin immunoreactivity in the benign and neoplastic human prostate. , 1985, Cancer research.

[15]  Morris Pollard,et al.  Spontaneous prostate adenocarcinomas in aged germfree Wistar rats. , 1973, Journal of the National Cancer Institute.

[16]  T. Vogt,et al.  Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. , 1994, Human pathology.

[17]  J. Epstein,et al.  Relationship of severe dysplasia to Stage A (incidental) adenocarcinoma of the prostate , 1990, Cancer.

[18]  S. Shain,et al.  Prostate carcinogenesis in the AXC rat. , 1977, Oncology.

[19]  J. Geller.  Overview of benign prostatic hypertrophy. , 1989, Urology.

[20]  W. Sakr,et al.  DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate , 1993, The Prostate.

[21]  Kathleen R. Cho,et al.  Relationship of severe dysplasia to Stage B adenocarcinoma of the prostate , 1990, Cancer.

[22]  D. Bostwick,et al.  Intraductal dysplasia: a premalignant lesion of the prostate. , 1986, Human pathology.

[23]  R. Zarbo,et al.  Computerized static DNA ploidy analysis of prostatic intraepithelial neoplasia. , 1993, Archives of pathology & laboratory medicine.

[24]  P. Lange,et al.  Prostate‐specific antigen and premalignant change: Implications for early detection , 1989, CA: a cancer journal for clinicians.

[25]  I. Leav,et al.  Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. , 1988, Journal of the National Cancer Institute.

[26]  T. Stamey,et al.  Microcarcinoma in the prostate: its association with duct-acinar dysplasia. , 1991, Human pathology.

[27]  P. Scardino,et al.  Pathologic basis of the sonographic appearance of the normal and malignant prostate. , 1989, The Urologic clinics of North America.

[28]  C. Busch,et al.  Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy. , 1993, British journal of urology.

[29]  C. Cooper,et al.  Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines. , 1984, Cancer research.

[30]  R. Montironi,et al.  Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN). , 1993, Anticancer research.

[31]  M Petein,et al.  Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. , 1991, American journal of clinical pathology.

[32]  D. Bostwick,et al.  Decrease of prostatic intraepithelialneoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy , 1994 .

[33]  J. Epstein,et al.  Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. , 1993, Human pathology.

[34]  J. Epstein,et al.  Blood Group Antigen Expression in Dysplasia: and Adenocarcinoma of the Prostate , 1990, The American journal of surgical pathology.

[35]  Young Id,et al.  Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. , 1993 .

[36]  M Scarpelli,et al.  Prostatic Intra-epithelial Neoplasia: Qualitative and Quantitative Analyses of the Blood Capillary Architecture on Thin Tissue Sections , 1993 .

[37]  D. Bostwick,et al.  The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials. , 1994, Journal of cellular biochemistry. Supplement.

[38]  J. Isaacs.  The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis. , 1984, Cancer research.

[39]  D. Bostwick,et al.  Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. , 1994, Cancer research.

[40]  Utz Dc.  Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure. , 1984 .

[41]  M. Amin,et al.  Putative precursor lesions of prostatic adenocarcinoma: fact or fiction? , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[42]  D. Bostwick,et al.  Architectural patterns of high-grade prostatic intraepithelial neoplasia. , 1993, Human pathology.

[43]  W. Grizzle,et al.  Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. , 1994, Journal of the National Cancer Institute.

[44]  B. Wullich,et al.  Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. , 1993, Cancer research.

[45]  I. Leav,et al.  Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia. , 1988, American journal of clinical pathology.

[46]  D. Bostwick,et al.  The pathology of early prostate cancer , 1989, CA: a cancer journal for clinicians.

[47]  J. Drago,et al.  Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience. , 1989, Urology.

[48]  N. Weidner,et al.  Nucleolar Organizer Regions (NOR) in Hyperplastic and Neoplastic Prostate Disease , 1990, The American journal of surgical pathology.

[49]  D. Grignon,et al.  Allelic loss in locally metastatic, multisampled prostate cancer. , 1994, Cancer research.

[50]  J. Kovi,et al.  Ductal spread in prostatic carcinoma , 1985, Cancer.

[51]  P. Härkönen,et al.  Prostatic dysplasia associated with increased expression of c-myc in neonatally estrogenized mice. , 1993, The Journal of urology.

[52]  T. Stamey,et al.  Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume , 1993, Cancer.

[53]  G. Haas,et al.  The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. , 1993, The Journal of urology.

[54]  P. Humphrey,et al.  Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues. , 1992, Surgical oncology.

[55]  R. Montironi,et al.  Quantitative analysis of prostatic intraepithelial neoplasia on tissue sections. , 1990, Analytical and quantitative cytology and histology.

[56]  D. Bostwick,et al.  Neuroendocrine Differentiation in Prostatic Intraepithelial Neoplasia and Adenocarcinoma , 1994, The American journal of surgical pathology.

[57]  R. Seljelid,et al.  Cellular atypia in the prostate. , 1971, Scandinavian journal of urology and nephrology.

[58]  A. Reith,et al.  DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas. , 1993, Analytical and quantitative cytology and histology.

[59]  D. Grignon,et al.  Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. , 1989, Urology.

[60]  M. Brawer,et al.  Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. , 1991, The American journal of pathology.

[61]  D. Bostwick,et al.  Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. , 1993, Human pathology.

[62]  D. Bostwick.  Prostatic intraepithelial neoplasia (PIN): Current concepts , 1992, Journal of cellular biochemistry. Supplement.

[63]  D. Bostwick,et al.  Panel III: Report of the committee on staging and pathology , 1992, Cancer.

[64]  D. Chopin,et al.  Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. , 1993, The American journal of pathology.

[65]  N. Weidner,et al.  Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma. , 1993, Archives of pathology & laboratory medicine.

[66]  M. Sporn,et al.  Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. , 1991, Cancer research.

[67]  T. P. Cameron,et al.  Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/segHapBR rat. , 1980, Laboratory investigation; a journal of technical methods and pathology.